Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence

Hyperfine (HYPR) announced that it has received FDA clearance for a new multi-direction diffusion-weighted imaging software sequence. This advancement delivers substantially improved image quality and diagnostic confidence for stroke detection, marking a significant expansion of the Swoop system’s clinical capabilities in acute neurological care.